Storys zum Thema Medizin, Gesundheit

STADA Arzneimittel AG

2

Press Release: STADA’s Strong Growth Journey Continues in 2025

Helmholtz Munich

100,000 Participants Screened for Early-Stage Type 1 Diabetes in the EDENT1FI Project

EDENT1FI (“European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception”), a research project led by Prof. Anette-Gabriele Ziegler from Helmholtz Munich and Prof. Chantal Mathieu from the KU Leuven, has reached an important milestone toward its goal, having screened 100,000 of the more than 200,000 children and adolescents ...

Grünenthal Group

Grünenthal licenses exclusive South Korean rights to Qutenza® to BCWorld Pharm

Aachen, Germany & Yeoju, South Korea (ots) - Grünenthal, a global leader in pain management and related diseases, and BCWorld Pharm Co., Ltd. ("BCWP"), a specialty company actively expanding and diversifying its pain management portfolio through global open innovation partnerships, announced today that they have entered into a definitive agreement whereby BCWP will ...

Grünenthal Group

Grünenthal takes full ownership of Grünenthal Meds, the joint venture established with Kyowa Kirin for its established medicines brands

Aachen, Germany (ots) - - Grünenthal acquired Kyowa Kirin International's 49% stake in 'Grünenthal Meds', a joint venture formed in 2023 to market the established medicines portfolio from Kyowa Kirin International. - Through this acquisition, Grünenthal assumes the sole responsibility of a portfolio comprising 12 ...

Fraunhofer IOF

3

Quantum communication in real-world operation

Ottobock SE & Co. KGaA

Ottobock invests in future technology from Blue Arbor Technologies, Inc.

Medi-Globe GmbH

3

Medi-Globe Launches mAI  Companion® - the World’s First Real‑Time  AI  Assistant for Pancreatic  EUS, Co‑Developed  with  IHU  Strasbourg  / Now  MDR  CE‑Marked  and  Available  for  Clinical  Use  in  Europe

Grünenthal Group

Grünenthal licenses exclusive Australian rights to Qutenza® to Clinect

Aachen, Germany & Victoria, Australia (ots) - Grünenthal, a global leader in pain management and related diseases, and Clinect Pty Ltd ("Clinect"), an Australian based company focussed on supporting access to unique products, announced today that they have entered into a definitive agreement whereby Clinect will have the exclusive Australian rights to Qutenza®, a ...

Europäischer Rechnungshof - European Court of Auditors

EU’s ambitious plan to combat cancer suffers from uncertainty

DHL Group

5

PM: DHL Group stärkt Logistik für das weltweite Gesundheitswesen durch Ausbau des Kühlkettennetzwerks in der Luftfracht / PR: DHL Group Expands Airfreight Cold Chain Network to Advance Global Health Logistics

Grünenthal Group

Grünenthal’s proprietary NaV 1.8 inhibitor enters clinical development

Aachen, Germany (ots) - Grünenthal announced today that the first healthy volunteers have been enrolled in a Phase I trial of its voltage-gated sodium channel (NaV) 1.8 inhibitor. The orally administered investigational medicine aims to provide a non-opioid therapy option across a range of acute and chronic pain conditions. Full results of the trial are expected in ...

Ottobock SE & Co. KGaA

Record results for Ottobock: Double-digit growth, strong profit growth, positive outlook

STADA Arzneimittel AG

Press Release: STADA invests more than €85m in Saudi Arabia manufacturing hub

STADA Arzneimittel AG

Press Release: STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi

STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi - European Commission grants approval for Gotenfia®, a golimumab biosimilar to Simponi® that was developed by Bio-Thera and will be marketed by STADA ...

Europäischer Rechnungshof - European Court of Auditors

Koronakriisin jälkeinen EU:n 650 miljardin euron elpymisrahasto: varoja suojataan petoksilta hajanaisesti

Grünenthal Group

Grünenthal licenses exclusive Canadian rights to testosterone replacement therapy Nebido® to Apotex

Aachen, Germany & Toronto, Canada (ots) - Grünenthal, a global leader in pain management and related diseases, and Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, today announced they have entered into a licensing agreement whereby Apotex will have the exclusive Canadian rights to ...

Servier Deutschland GmbH

Servier delivers solid performance in 2024/25 and confirms its forecasts for 2030

Suresnes, France (ots/PRNewswire) - - Servier reported Group revenues of €6.9 billion for 2024/25, up 16.2% from 2023/24. - Growth over the financial year was driven by increased sales in oncology, particularly in the United States. - Several partnership agreements in oncology and neurology strengthen the Group's R&D portfolio in rare diseases. - Achieving 2025 ...

STADA Arzneimittel AG

Press release: STADA’s Head of Communications Frank Staud additionally leads Global Government Affairs

ADAC SE

2

The Premier Forum for Air Rescue Experts: AirMed World Congress 2026 in Munich

GEA Group Aktiengesellschaft

4

GEA to equip BFF’s food-grade line for precision and biomass fermentation

ORTEC BV

ORTEC expands German healthcare footprint with strategic acquisition of Klages &  Partner / Acquisition adds over 200 healthcare customers and sector-specific workforce management expertise to ORTEC’s portfolio

Acousia Therapeutics GmbH

Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity

Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small ...

European Spas Association

30 Years of European Spas: Nature, Natural Remedies and Climate Health as Europe’s Unique Strength

LAUDA DR. R. WOBSER GMBH & CO. KG

LAUDA Once Again Global Market Leader